SCHEMBL14262507

SCHEMBL14262507

CCc1nn(C)c(C(=O)NCc2ccc(C(C)(C)C[18F])cc2)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 7/20 0.53
▸ RAB9A P51151 6/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ GALR3 O60755 1/20 0.53
▸ NR2F2 P24468 1/20 0.53
▸ ATM Q13315 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NPC1 O15118 4/20 0.41
▸ POLB P06746 2/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ ALPL P05186 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ ALPG P10696 1/20 0.40
▸ NR1I2 O75469 1/20 0.39
▸ AHR P35869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tebufenpyrad SCHEMBL26848 0.89 LMNA (0.59) LMNARAB9ASMN1; SMN2KMT2AGALR3
Tebufenpyrad SCHEMBL8407688 0.89 LMNA (0.59) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL15220664 0.83 LMNA (0.60) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL19185953 0.82 LMNA (0.54) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL14262522 0.82 LMNA (0.54) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL20968014 0.82 LMNA (0.59) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL11938500 0.82 LMNA (0.59) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL11938565 0.81 RAB9A (0.48) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL19185749 0.81 RAB9A (0.48) LMNARAB9ASMN1; SMN2KMT2AGALR3
SCHEMBL11938496 0.81 LMNA (0.72) LMNARAB9ASMN1; SMN2KMT2AGALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7344702-B2 Contrast agents for myocardial perfusion imaging BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-03-18 — — US disclosed
Send feedback